Universe Pharmaceuticals ... (UPC)
0.51
0.01 (1.74%)
At close: Jan 28, 2025, 2:00 PM
Company Description
Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China.
It offers products for the treatment of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications.
The company also distributes and sells third-party producers, including biomedical drugs, medical instruments, traditional Chinese medicine pieces products, and dietary supplements.
Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains.
The company was incorporated in 2019 and is based in Ji'An, China.
Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.
Universe Pharmaceuticals INC
| Country | CN |
| IPO Date | Mar 23, 2021 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 225 |
| CEO | Gang Lai |
Contact Details
Address: No. 265, Jingjiu Avenue Ji'An, CN | |
| Website | https://www.universe-pharmacy.com |
Stock Details
| Ticker Symbol | UPC |
| Exchange | NASDAQ |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| CIK Code | 0001809616 |
| CUSIP Number | G9442G104 |
| ISIN Number | KYG9442G1120 |
| Employer ID | 00-0000000 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Gang Lai | Chief Executive Officer & Chairman |
| Baochang Liu | Chief Operating Officer |
| Lin Yang | Chief Financial Officer & Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 27, 2025 | NT 20-F | Filing |
| Jan 03, 2025 | SCHEDULE 13G | Filing |
| Dec 12, 2024 | 6-K | Filing |
| Dec 09, 2024 | 424B5 | Filing |
| Nov 13, 2024 | 6-K | Filing |
| Nov 01, 2024 | 6-K | Filing |
| Oct 10, 2024 | 6-K | Filing |
| Sep 27, 2024 | 6-K | Filing |
| Sep 20, 2024 | 6-K | Filing |
| Sep 03, 2024 | 6-K | Filing |